vimarsana.com

Page 3 - அலுவலகம் ஆஃப் ப்ரெஸ் உறவுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

U S provides $25 million in vaccination support to India - India

U.S. provides $25 million in vaccination support to India Format press@usaid.gov The United States continues to take decisive action to protect both the American people and the world’s most vulnerable by providing safe and effective vaccines around the world. Today, during his first trip to India, U.S. Secretary of State Antony Blinken announced that the U.S. government, through the U.S. Agency for International Development (USAID), will provide $25 million (about 185 crore rupees) to support India’s COVID-19 vaccination program. With this assistance, USAID will partner with India’s Ministry of Health and Family Welfare, as well as state governments, to support vaccine supply chain logistics, address misinformation and vaccine hesitancy, and train healthcare workers to deliver vaccines safely and effectively across India. USAID will also collaborate with key stakeholders, including the Bill & Melinda Gates Foundation, UNICEF, the WHO, and GAVI, to promote equitable vaccine

Joint investment plan to boost vaccine manufacturing capacity in Africa - World

Joint investment plan to boost vaccine manufacturing capacity in Africa Format Office of Press Relations press@usaid.gov Today, the United States International Development Finance Corporation (DFC) in collaboration with the World Bank Group, Germany, and France, announced a joint investment to boost vaccine manufacturing capacity in Africa. As Vice Chair of DFC’s Board of Directors, I was proud to vote yes on this deal. This financing will enable a South African business to ramp up manufacturing capacity and produce more than 500 million doses of the Johnson & Johnson vaccine by the end of 2022. If the COVID-19 pandemic has revealed anything, it’s that vaccine manufacturing must be dramatically scaled up. Africa currently imports 99 percent of its vaccines. The United States is committed to sustainably boosting Africa’s vaccine manufacturing capacity and vaccine access, while taking bold, immediate action to help African nations fight COVID-19.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.